Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $27.8, a high estimate of $33.00, and a low estimate of $21.00. This current ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $5.0, with a high estimate of $9.00 and a low estimate of $3.00. This current average has ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $82.89, a high estimate of ...

Vertiv Holdings VRT underwent analysis by 16 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to ...

Analysts have recently evaluated Regenxbio and provided 12-month price targets. The average target is $38.4, accompanied by a high estimate of $52.00 and a low estimate of $17.00. Highlighting a 8.13% ...

Toll Brothers offers an annual dividend yield of 0.76%. So, how can investors exploit its dividend yield to pocket a regular ...

On CNBC's "Halftime Report Final Trades," Joe Terranova of Virtus Investment Partners named Amphenol as his final trade.

Short-seller Citron targets Palantir, arguing the AI stock is overvalued. Find out why OpenAI's valuation suggests a ...

Foxconn, owned by Hon Hai Precision Industry (OTC: HNHPF), the prominent supplier for Apple Inc. (NASDAQ: AAPL), has seen its ...

Elizabeth Warren warns Trump's Big Beautiful Bill could force hundreds of hospitals to close, leaving rural areas at risk.

The company recorded 14k new insured registrations in China, a 60% surge compared to the previous quarter for Tesla, data ...